Latanoprost Stada (Latanoprost)

Latanoprost binds to prostaglandin F (FP) receptors in the eye’s ciliary body, increasing the uveoscleral outflow of aqueous humor. This enhanced drainage reduces intraocular pressure, which is the primary therapeutic goal in glaucoma management.

The dosing regimen for Latanoprost Stada is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing must follow the clinician’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intraocular pressure reduction. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more favorable dosing convenience and comparable efficacy.

Latanoprost Stada eye drops should be stored at room temperature, below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and discard any solution that has changed in appearance.

The medication is applied as a single drop into the conjunctival sac of the prescribed eye(s) once daily, usually in the evening. Patients should avoid touching the tip of the bottle to the eye or any other surface to maintain sterility.

Serious risks, though rare, include severe eye inflammation (uveitis or iritis), allergic reactions with swelling or rash, sudden vision loss, and ocular infections. Any of these symptoms require immediate medical attention.

Patients with known hypersensitivity to latanoprost or any component of the formulation should avoid using the product. Caution is also advised for individuals with active ocular infections or inflammation until these conditions are resolved.